St. Johns Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $932K | Buy |
4,286
+67
| +2% | +$14.9K | 0.39% | 63 |
|
|
2025
Q4 | $964K | Hold |
4,219
| – | – | 0.4% | 57 |
|
|
2025
Q3 | $977K | Buy |
4,219
+28
| +0.7% | +$5.7K | 0.42% | 58 |
|
|
2025
Q2 | $778K | Buy |
4,191
+305
| +8% | +$56.7K | 0.36% | 67 |
|
|
2025
Q1 | $814K | Sell |
3,886
-107
| -3% | -$20.8K | 0.4% | 63 |
|
|
2024
Q4 | $710K | Sell |
3,993
-82
| -2% | -$15.1K | 0.33% | 68 |
|
|
2024
Q3 | $805K | Buy |
4,075
+40
| +1% | +$7.46K | 0.38% | 69 |
|
|
2024
Q2 | $692K | Buy |
4,035
+27
| +0.7% | +$4.47K | 0.33% | 71 |
|
|
2024
Q1 | $730K | Buy |
4,008
+624
| +18% | +$108K | 0.35% | 71 |
|
|
2023
Q4 | $524K | Sell |
3,384
-104
| -3% | -$15.2K | 0.27% | 73 |
|
|
2023
Q3 | $520K | Buy |
3,488
+15
| +0.4% | +$2.2K | 0.3% | 70 |
|
|
2023
Q2 | $468K | Sell |
3,473
-1,671
| -32% | -$245K | 0.25% | 77 |
|
|
2023
Q1 | $820K | Sell |
5,144
-2,206
| -30% | -$337K | 0.48% | 59 |
|
|
2022
Q4 | $1.19M | Sell |
7,350
-116
| -2% | -$17.8K | 0.71% | 48 |
|
|
2022
Q3 | $1M | Buy |
7,466
+287
| +4% | +$41.2K | 0.66% | 47 |
|
|
2022
Q2 | $1.1M | Sell |
7,179
-143
| -2% | -$21.9K | 0.7% | 46 |
|
|
2022
Q1 | $1.19M | Sell |
7,322
-162
| -2% | -$23.5K | 0.63% | 52 |
|
|
2021
Q4 | $1.01M | Sell |
7,484
-95
| -1% | -$11.2K | 0.52% | 53 |
|
|
2021
Q3 | $818K | Buy |
7,579
+330
| +5% | +$37.7K | 0.45% | 58 |
|
|
2021
Q2 | $817K | Buy |
7,249
+74
| +1% | +$8.33K | 0.44% | 59 |
|
|
2021
Q1 | $776K | Buy |
7,175
+121
| +2% | +$12.9K | 0.45% | 58 |
|
|
2020
Q4 | $756K | Sell |
7,054
-181
| -3% | -$17.4K | 0.47% | 57 |
|
|
2020
Q3 | $634K | Buy |
7,235
+451
| +7% | +$42.5K | 0.43% | 56 |
|
|
2020
Q2 | $666K | Buy |
6,784
+281
| +4% | +$24.7K | 0.49% | 54 |
|
|
2020
Q1 | $495K | Buy |
6,503
+557
| +9% | +$47.4K | 0.44% | 59 |
|
|
2019
Q4 | $526K | Sell |
5,946
-280
| -4% | -$23.2K | 0.37% | 67 |
|
|
2019
Q3 | $471K | Sell |
6,226
-130
| -2% | -$8.91K | 0.35% | 68 |
|
|
2019
Q2 | $462K | Sell |
6,356
-195
| -3% | -$15.3K | 0.34% | 70 |
|
|
2019
Q1 | $528K | Buy |
6,551
+790
| +14% | +$64.6K | 0.41% | 67 |
|
|
2018
Q4 | $531K | Buy |
5,761
+559
| +11% | +$49.2K | 0.47% | 65 |
|
|
2018
Q3 | $492K | Buy |
5,202
+275
| +6% | +$26.1K | 0.37% | 69 |
|
|
2018
Q2 | $456K | Buy |
4,927
+4,887
| +12,218% | +$477K | 0.34% | 71 |
|
|
2018
Q1 | $4K | Hold |
40
| – | – | ﹤0.01% | 156 |
|
|
2017
Q4 | $4K | Hold |
40
| – | – | ﹤0.01% | 135 |
|
|
2017
Q3 | $4K | Hold |
40
| – | – | ﹤0.01% | 162 |
|
|
2017
Q2 | $3K | Hold |
40
| – | – | ﹤0.01% | 149 |
|
|
2017
Q1 | $3K | Hold |
40
| – | – | ﹤0.01% | 147 |
|
|
2016
Q4 | $3K | Hold |
40
| – | – | ﹤0.01% | 150 |
|
|
2016
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 136 |
|
|
2016
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 144 |
|
|
2016
Q1 | $2K | Buy |
+40
| New | +$2.23K | ﹤0.01% | 141 |
|
Other funds holding ABBV
VCM
VPM
St. Johns Investment Management's ABBV Position: Q1 2026 in Review
St. Johns Investment Management increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $14.9K and bringing the position to 4,286 shares worth $932K. The position accounts for 0.39% of the portfolio, ranked #63.
St. Johns Investment Management first reported a position in ABBV in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.19M in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- St. Johns Investment Management held 4,286 shares of AbbVie worth $932K as of Q1 2026.
- St. Johns Investment Management bought 67 AbbVie shares in Q1 2026, an estimated $14.9K.
- AbbVie made up 0.39% of St. Johns Investment Management's portfolio in Q1 2026, its #63 holding.
- St. Johns Investment Management first reported a position in AbbVie in Q1 2016 and has held it in 41 quarters since.
- St. Johns Investment Management's AbbVie position peaked at $1.19M in Q4 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.